RCT: In children with relapsing steroid-sensitive nephrotic syndrome with acute respiratory tract infection, a daily low dose of prednisolone did not reduce the risk of relapse.
27 Jan, 2022 | 09:32h | UTCCommentary: PREDNOS 2: Prednisolone Doesn’t Lower Relapse Risks in Kids with Nephrotic Syndrome – Physician’s Weekly
Commentary on Twitter
In a large non-selected sample of children (365) with relapsing steroid sensitive nephrotic syndrome, the PREDNOS 2 RCT has shown that low dose prednisolone given for 6 days at the start of an URTI does not reduce the risk of relapse https://t.co/9271PHQh0r
— JAMA Pediatrics (@JAMAPediatrics) December 20, 2021